476 related articles for article (PubMed ID: 33389038)
1. Identifying Parkinson's disease with mild cognitive impairment by using combined MR imaging and electroencephalogram.
Zhang J; Gao Y; He X; Feng S; Hu J; Zhang Q; Zhao J; Huang Z; Wang L; Ma G; Zhang Y; Nie K; Wang L
Eur Radiol; 2021 Oct; 31(10):7386-7394. PubMed ID: 33389038
[TBL] [Abstract][Full Text] [Related]
2. An SBM-based machine learning model for identifying mild cognitive impairment in patients with Parkinson's disease.
Zhang J; Li Y; Gao Y; Hu J; Huang B; Rong S; Chen J; Zhang Y; Wang L; Feng S; Wang L; Nie K
J Neurol Sci; 2020 Nov; 418():117077. PubMed ID: 32798842
[TBL] [Abstract][Full Text] [Related]
3. Machine learning trained with quantitative susceptibility mapping to detect mild cognitive impairment in Parkinson's disease.
Shibata H; Uchida Y; Inui S; Kan H; Sakurai K; Oishi N; Ueki Y; Oishi K; Matsukawa N
Parkinsonism Relat Disord; 2022 Jan; 94():104-110. PubMed ID: 34906915
[TBL] [Abstract][Full Text] [Related]
4. Phase lag index and spectral power as QEEG features for identification of patients with mild cognitive impairment in Parkinson's disease.
Chaturvedi M; Bogaarts JG; Kozak Cozac VV; Hatz F; Gschwandtner U; Meyer A; Fuhr P; Roth V
Clin Neurophysiol; 2019 Oct; 130(10):1937-1944. PubMed ID: 31445388
[TBL] [Abstract][Full Text] [Related]
5. Detection of mild cognitive impairment in Parkinson's disease using gradient boosting decision tree models based on multilevel DTI indices.
Chen B; Xu M; Yu H; He J; Li Y; Song D; Fan GG
J Transl Med; 2023 May; 21(1):310. PubMed ID: 37158918
[TBL] [Abstract][Full Text] [Related]
6. Brain connectivity markers in advanced Parkinson's disease for predicting mild cognitive impairment.
Lin H; Liu Z; Yan W; Zhang D; Liu J; Xu B; Li W; Zhang Q; Cai X
Eur Radiol; 2021 Dec; 31(12):9324-9334. PubMed ID: 34109485
[TBL] [Abstract][Full Text] [Related]
7. Neuroanatomical changes in early Parkinson's disease with mild cognitive impairment: a VBM study; the Parkinson's Disease Cognitive Impairment Study (PaCoS).
Donzuso G; Monastero R; Cicero CE; Luca A; Mostile G; Giuliano L; Baschi R; Caccamo M; Gagliardo C; Palmucci S; Zappia M; Nicoletti A
Neurol Sci; 2021 Sep; 42(9):3723-3731. PubMed ID: 33447925
[TBL] [Abstract][Full Text] [Related]
8. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
[TBL] [Abstract][Full Text] [Related]
9. Assessing Mild Cognitive Impairment in Parkinson's Disease by Magnetic Resonance Quantitative Susceptibility Mapping Combined Voxel-Wise and Radiomic Analysis.
Zhao Y; Qu H; Wang W; Liu J; Pan Y; Li Z; Xu G; Hu C
Eur Neurol; 2022; 85(4):280-290. PubMed ID: 35313305
[TBL] [Abstract][Full Text] [Related]
10. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
[TBL] [Abstract][Full Text] [Related]
11. Structural connectivity from DTI to predict mild cognitive impairment in de novo Parkinson's disease.
Huang X; He Q; Ruan X; Li Y; Kuang Z; Wang M; Guo R; Bu S; Wang Z; Yu S; Chen A; Wei X
Neuroimage Clin; 2024; 41():103548. PubMed ID: 38061176
[TBL] [Abstract][Full Text] [Related]
12. Identification of metabolic correlates of mild cognitive impairment in Parkinson's disease using magnetic resonance spectroscopic imaging and machine learning.
Cengiz S; Arslan DB; Kicik A; Erdogdu E; Yildirim M; Hatay GH; Tufekcioglu Z; Uluğ AM; Bilgic B; Hanagasi H; Demiralp T; Gurvit H; Ozturk-Isik E
MAGMA; 2022 Dec; 35(6):997-1008. PubMed ID: 35867235
[TBL] [Abstract][Full Text] [Related]
13. Predicting the occurrence of mild cognitive impairment in Parkinson's disease using structural MRI data.
Beheshti I; Ko JH
Front Neurosci; 2024; 18():1375395. PubMed ID: 38699676
[TBL] [Abstract][Full Text] [Related]
14. Structural changes in the retina and serum HMGB1 levels are associated with decreased cognitive function in patients with Parkinson's disease.
Liang K; Li X; Guo Q; Ma J; Yang H; Fan Y; Yang D; Shi X; She Z; Qi X; Gu Q; Chen S; Zheng J; Li D
Neurobiol Dis; 2024 Jan; 190():106379. PubMed ID: 38104911
[TBL] [Abstract][Full Text] [Related]
15. Morphometric magnetic resonance imaging cortico-subcortical features in Parkinson's disease with mild cognitive impairment.
Cicero CE; Donzuso G; Luca A; Davì M; Baschi R; Mostile G; Giuliano L; Palmucci S; Salerno A; Monastero R; Nicoletti A; Zappia M
Eur J Neurol; 2022 Nov; 29(11):3197-3204. PubMed ID: 35790057
[TBL] [Abstract][Full Text] [Related]
16. Voxel-wise meta-analysis of structural changes in gray matter of Parkinson's disease patients with mild cognitive impairment.
Qin B; Yang MX; Gao W; Zhang JD; Zhao LB; Qin HX; Chen H
Braz J Med Biol Res; 2020; 53(6):e9275. PubMed ID: 32428131
[TBL] [Abstract][Full Text] [Related]
17. Disrupted Resting-state Functional Connectivity of the Nucleus Basalis of Meynert in Parkinson's Disease with Mild Cognitive Impairment.
Zhang C; Wu C; Zhang H; Dou W; Li W; Sami MU; Xu K
Neuroscience; 2020 Aug; 442():228-236. PubMed ID: 32659339
[TBL] [Abstract][Full Text] [Related]
18. Machine learning based on functional and structural connectivity in mild cognitive impairment.
Li Y; Shao Y; Wang J; Liu Y; Yang Y; Wang Z; Xi Q
Magn Reson Imaging; 2024 Jun; 109():10-17. PubMed ID: 38408690
[TBL] [Abstract][Full Text] [Related]
19. fNIRS-based graph frequency analysis to identify mild cognitive impairment in Parkinson's disease.
Shu Z; Wang J; Cheng Y; Lu J; Lin J; Wang Y; Zhang X; Yu Y; Zhu Z; Han J; Wu J; Yu N
J Neurosci Methods; 2024 Feb; 402():110031. PubMed ID: 38040127
[TBL] [Abstract][Full Text] [Related]
20. Alterations of regional homogeneity in Parkinson's disease with mild cognitive impairment: a preliminary resting-state fMRI study.
Li MG; Liu TF; Zhang TH; Chen ZY; Nie BB; Lou X; Wang ZF; Ma L
Neuroradiology; 2020 Mar; 62(3):327-334. PubMed ID: 31822931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
